No3-4(5) 2022
Back to the issue
DOI 10.37219/2528-8253-2022-3-65 |
Bezega M
Disorder of sound conduction function in patients with COVID-19 |
Mychailo Bezega
Poltava State Medical University
E-mail: bezega_lor@ukr.net, lorbezega@gmail.com
ORCID ID: https://orcid.org/0000-0002-1250-1190 |
Abstract
Topicality: Recently, due to the pandemic of the new virus COVID-19,
a significant number of patients have been observed in almost all countries
of the world, presenting various clinical manifestations of the disease. The
auditory system can also suffer when infected with COVID-19. In the
publications of several authors, observation of concomitant
cochleovestibular manifestations in COVID-19 is presented. In addition,
there are reports of sensorineural hearing loss, tinnitus, vertigo, otitis,
and ear pain. However, there is still not enough information on auditory
system lesions in patients with COVID-19 in the literature; so far, there
are no thorough studies in this direction.
Aim: to investigate the state of auditory function in patients with
COVID-19 with sound conduction disorders.
Materials and methods: An analysis of the clinical and instrumental
examination results of 47 patients with COVID-19 with auditory function
disorders was carried out. The results of the questionnaire,
otolaryngological examination, subjective audiometry, and acoustic impedance
measurement were analyzed. The investigation was carried out using
audiometers АС-40 ("Interacoustics," Denmark), and MA 31 (Germany),
impedance audiometers АТ-235, Ad 229e, ("Interacoustics," Denmark), and
MAICO (Germany). In addition, an endoscopic examination of the nasal cavity
was carried out using the workplace of an otorhinolaryngologist with the
Mega Medical NET-1100 endovideo complex.
Results and their discussion: The analysis of the survey of 147
patients revealed that damage to the auditory system mainly occurred after a
particular time after suffering from the disease due to COVID-19. Some
patients (15.6%) had a progression of pre-existing SNS; in them, the first
signs of deterioration of auditory function were usually noted a few days
after the onset of the disease. In total, among 147 interviewed patients, 51
people (34.7%) indicated certain disorders of the auditory system. At the
same time, the patients noted such symptoms as tinnitus, decreased hearing
acuity, impaired speech intelligibility, poor tolerance to loud sounds,
blocked ears, and unpleasant sensations in the ears (feeling of pressure,
tingling, dull pain).
During the instrumental examination of 47 patients with COVID-19 with
complaints from the auditory system, we mainly observed sensorineural
disorders of auditory function. In 23.4% of cases, there was a conductive
component. In the majority of such patients after COVID-19, they do not
immediately notice symptoms in the auditory system. Instead, they have an
unexpressed character and appear over time after the disease. Such hearing
disorders are often
accompanied by secretory otitis, tubootitis, and auditory tube patency
disorder.
It should be noted that in patients (19.1%) with a conductive component,
there were changes in the anatomical structures of the nose and nasopharynx
in the form of curvature of the nasal foramen, hypertrophy of the nasal
shells, tubular rollers, etc. Conservative therapy with vasoconstrictor,
anti-inflammatory, and hormonal drugs is not always effective in such cases.
In most cases, according to our observations, minimally invasive surgical
intervention in the form of tympanopuncture was required.
Therefore, the disease of COVID-19 is often (34.7%) accompanied, in addition
to other symptoms, by a decrease in hearing function. Lesions of the
auditory system manifest in the form of perceptual disorders with a
pronounced conductive component (23.4%).On the other hand, when presenting
patients with persistent but vague hearing impairments, it should be borne
in mind that this may be related to a previous illness of COVID-19.
Elucidation of this circumstance is vital for prescribing adequate treatment
and preventive measures.
Conclusions:
1. The disease with COVID-19 is often (34.7%) accompanied, in addition to
other symptoms, by hearing impairment due to damage to the auditory system,
both perceptual and conductive. Mainly, such manifestations occur after a
particular time after the disease.
2. Hearing disorders with COVID-19 often have a conductive component (23.4%
of cases). Such disorders can be observed directly during the disease and,
in some patients, persist for a long time after recovery. Conductive
disorders of auditory function can also develop somewhat delayed from the
onset of the disease, have an indistinct protracted nature, and the
manifestations can intensify even after the end of the active phase of the
disease.
3. Conductive disorders of auditory function in COVID-19 are poorly amenable
to traditional conservative treatment methods and require more active
measures, including minimally invasive surgical intervention in the form of
tympanopuncture.
4. For patients with COVID-19 who have complaints of hearing impairment, it
is advisable to undergo an instrumental audiological examination. |
Keywords
COVID-19, auditory function, conductive hearing impairment. |
Reference
- Almufarrij I, Uus K, Munro KJ. Does Coronavirus Affect the
Audio-Vestibular System? a Rapid Systematic Review. Int J Audiol.
2020;59(7):487-91. doi: 10.1080/14992027.2020.1776406.
- Asadi-Pooya AA, Simani L. Central nervous system manifestations of
COVID-19: A systematic review. J Neurol Sci. 2020;413:116832.
doi:10.1016/j.jns. 2020.116832.
- Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 virus
targeting the CNS: tissue distribution, host-virus interaction, and
proposed neurotropic mechanisms. ACS Chem Neurosci. 2020;11 (7):995-8.
doi: 10.1021/acschemneuro.0c00122.
- Ciorba A, Corazzi V, Skarzynski PH, Skarzynska MB, Bianchini C,
Pelucchi S, Hatzopoulos S. Don’t Forget Ototoxicity During the SARSCoV-2
(Covid-19) Pandemic. Int J Immunopathol Pharmacol. 2020;
34:2058738420941754. doi: 10.1177/2058738420941754.
- Degen C, Lenarz T, Willenborg K. Acute profound sensorineural
hearing loss after COVID-19 pneumonia. Mayo Clin Proc.
2020;95(8):1801-3. doi:10.1016/j.mayocp.2020.05.034.
- Ellul MA, Benjamin L, Singh B, Lant S, Michael BD, Easton A, et al.
Neurological associations of COVID-19. Lancet Neurol. 2020;19(9):767-83.
doi:10.1016/S1474-4422(20)30221-0.
- Koumpa FS, Forde CT, Manjaly JG. Sudden irreversible hearing loss
post COVID-19. BMJ Case Rep. 2020;13(11):e238419. doi:
10.1136/bcr-2020-238419.
- Inciardi RM, Adamo M, Lupi L, Cani DS, Di Pasquale M, Tomasoni D, et
al. Characteristics and outcomes of patients hospitalized for COVID-19
and cardiac disease in Northern Italy. Eur Heart J. 2020;41(19):1821-9.
doi: 10.1093/eurheartj/ehaa388.
- Munro KJ, Uus K, Almufarrij I, Chaudhuri N, Yioe V. Persistent
self-reported changes in hearing and tinnitus in post-hospitalisation
COVID-19 cases. Int J Audiol. 2020;59(12):889-90. doi:
10.1080/14992027.2020.1798519.
- Kilic O, Kalcioglu MT, Cag Y, Tuysuz O, Pektas E, Caskurlu H, Cetın
F. Could sudden sensorineural hearing loss be the sole manifestation of
COVID-19? An investigation into SARS-COV-2 in the etiology of sudden
sensorineural hearing loss. Int J Infect Dis. 2020;97:208-11. doi:
10.1016/j.ijid.2020.06.023.
- Rhman SA, Wahid AA. COVID-19 and sudden sensorineural hearing loss:
a case report. Otolaryngol Case Rep. 2020;16:100198. doi: 10.1016/j.xocr.
2020.100198.
- Sriwijitalai W, Wiwanitkit V. Hearing loss and COVID-19: a note. Am
J Otolaryngol. 2020;41(3): 102473. doi: 10.1016/j.amjoto.2020.102473.
- Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L, et al. Nervous
system involvement after infection with COVID-19 and other coronaviruses.
Brain Behav Immun. 2020;87:18-22. doi: 10.1016/j.bbi.2020.03.031.
|
|